Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

YALÇIN Ş., ÖZGÜROĞLU M., shitara K., bang y. j., bartolomeo m. d., mandala m., ...More

Lancet, vol.392, no.10142, pp.123-133, 2018 (SCI-Expanded)

  • Publication Type: Article / Article
  • Volume: 392 Issue: 10142
  • Publication Date: 2018
  • Doi Number: 10.1016/s0140-6736(18)31257-1
  • Journal Name: Lancet
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.123-133
  • Hacettepe University Affiliated: Yes